Browse Category

Financial Forecasts 23 December 2025 - 24 December 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals Holdings, Inc. is in the spotlight on December 24, 2025 after a sharp selloff driven by a major regulatory development: the U.S. Food and Drug Administration recommended that Reviva run an additional Phase 3 trial for its lead schizophrenia candidate, brilaroxazine, before filing a New Drug Application. SEC+1
24 December 2025
···
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies Corporation is the center of the biotech tape on Wednesday, December 24, 2025, after Sanofi announced a deal to acquire the vaccine maker in an all-cash transaction valued at roughly $2.2 billion. The headline number investors are keying on: $15.50 per share in cash—a bid that reframes the near-term outlook for DVAX stock from “earnings and pipeline execution” to “deal timeline and closing risk.” Sanofi+1
24 December 2025
···
Nat++West Group Plc Stock (NWG): Buyback Momentum, Evelyn Partners Deal Watch, and What Forecasts Say as of 24 December 2025

Nat++West Group Plc Stock (NWG): Buyback Momentum, Evelyn Partners Deal Watch, and What Forecasts Say as of 24 December 2025

NatWest Group plc stock is heading into the Christmas break sitting close to its best levels in years, with investors balancing three big forces: an ongoing £750 million share buyback, a potential move in UK wealth management via the Evelyn Partners sale process, and a UK interest-rate environment that’s turning more supportive for borrowers—but trickier for bank margins. SEC+2Reuters+2
24 December 2025
···
Lloyds Banking Group (LLOY) Share Price on 24 December 2025: Latest News, 2026 Forecasts, Dividend Outlook and Key Risks

Lloyds Banking Group (LLOY) Share Price on 24 December 2025: Latest News, 2026 Forecasts, Dividend Outlook and Key Risks

Lloyds Banking Group plc stock is heading into the Christmas break with a familiar mix of momentum and mystery: the share price is hovering just below the psychologically loud £1 level, but the 2026 outlook still hinges on one giant unresolved storyline—UK motor finance redress—plus the quieter, slow-burn question of what falling interest rates do to a bank that’s famously UK-heavy.
24 December 2025
··
UOB Stock Price Today (SGX: U11): Shares Close at S$35.03 on Dec 24, 2025 as 2026 Margin Forecasts Take Center Stage

UOB Stock Price Today (SGX: U11): Shares Close at S$35.03 on Dec 24, 2025 as 2026 Margin Forecasts Take Center Stage

SINGAPORE — United Overseas Bank Limited shares ended the Christmas Eve session slightly higher, a small but notable outperformer among Singapore’s big three banks during thin, holiday-tilted trading. UOB rose 0.1% to S$35.03, even as the Straits Times Index slipped 0.06% ahead of the festive break. The Business Times+1
24 December 2025
··
DroneShield Limited (ASX:DRO) Stock Today: New $6.2m Asia-Pacific Military Contract, Governance Reset, and 2026 Analyst Forecasts (24 Dec 2025)

DroneShield Limited (ASX:DRO) Stock Today: New $6.2m Asia-Pacific Military Contract, Governance Reset, and 2026 Analyst Forecasts (24 Dec 2025)

Sydney | 24 December 2025 — DroneShield Limited stock is closing out 2025 with fresh contract momentum, after the counter-drone specialist disclosed a new $6.2 million Asia-Pacific military contract and reiterated a delivery-and-cash timetable that points mainly into 2026. The announcement lands as investors keep one eye on the order book and the other on a governance clean-up that began after a volatile November sell-off. Company Announcements+2ASX Announcements+2
24 December 2025
···
PLS Group Limited Stock (ASX: PLS) Surges Into Christmas Eve Spotlight: Latest News, Forecasts, and Analyst Outlook on 24 December 2025

PLS Group Limited Stock (ASX: PLS) Surges Into Christmas Eve Spotlight: Latest News, Forecasts, and Analyst Outlook on 24 December 2025

PLS Group Limited stock is back on traders’ radar on 24 December 2025, with the newly rebranded lithium heavyweight showing up among the ASX’s most-bought names in a holiday-shortened session. The move lands at a fascinating intersection: a lithium sector that’s been whip-sawed by price volatility, a resources complex being boosted by record-setting metals prices, and a company that’s actively reshaping its story from “single flagship mine” to “portfolio + downstream + Brazil.”
24 December 2025
··
Netskope Stock (NASDAQ: NTSK) Slides on Dec. 23, 2025: What’s Driving the Move, Fresh Earnings Context, and Wall Street Forecasts

Netskope Stock (NASDAQ: NTSK) Slides on Dec. 23, 2025: What’s Driving the Move, Fresh Earnings Context, and Wall Street Forecasts

In Tuesday’s session, Netskope fell about 5%–6%, with shares last around $18.6 after trading roughly between $18.50 and $19.54. Investing.com+1 That drop stood out because the broader market leaned bullish on the day—U.S. indexes pushed higher as the S&P 500 hovered near record territory. Investors
23 December 2025
···
Brown-Forman Stock (BF.B) Slides on Dec. 23, 2025: What’s Driving Jack Daniel’s Maker Today, Plus Analyst Forecasts and Key Levels

Brown-Forman Stock (BF.B) Slides on Dec. 23, 2025: What’s Driving Jack Daniel’s Maker Today, Plus Analyst Forecasts and Key Levels

Brown-Forman Corporation’s Class B shares are having the kind of December day investors don’t toast to: the stock is down about 5% in Tuesday trading, sliding to roughly $26.67 after opening near $28.06 and dipping as low as about $26.57. Trading volume is running in the low millions of shares, and the intraday range shows a sharp fade from the morning high near $28.09. markets.businessinsider.com
23 December 2025
·
Fermi Inc (FRMI) Stock Today, Dec. 23, 2025: Tenant Funding Deal Fallout, Amazon Rumor Denial, and What Analysts Forecast Next

Fermi Inc (FRMI) Stock Today, Dec. 23, 2025: Tenant Funding Deal Fallout, Amazon Rumor Denial, and What Analysts Forecast Next

Fermi Inc. is having the kind of December that turns a “future-of-AI-infrastructure” story into a market stress test. In Tuesday’s trading, FRMI was changing hands in the mid‑$8 range—down roughly mid‑single digits on the day—after a turbulent two weeks dominated by one headline: a prospective anchor tenant terminated a $150 million construction-funding agreement tied to Fermi’s Project Matador campus in Texas. MarketBeat+2StockAnalysis+2
23 December 2025
··
Gold Price Today at 1:38 (Dec. 23, 2025): Gold Holds Near $4,475 After Fresh Record High — Latest News, Forecasts and Analysis

Gold Price Today at 1:38 (Dec. 23, 2025): Gold Holds Near $4,475 After Fresh Record High — Latest News, Forecasts and Analysis

Gold prices are ending 2025 in headline-making fashion. At about 1:38 p.m. New York time on Tuesday, December 23, 2025, spot gold was quoted around $4,474.30/oz and $4,476.30/oz, after another sprint toward the $4,500 milestone. Kitco showed the day’s range around $4,430.40–$4,498.60, with gold priced near $143.85 per gram. Kitco
23 December 2025
·
Johnson & Johnson Stock (JNJ) Slips After Record $1.5B Talc Verdict: News, Forecasts, and What to Watch Into 2026

Johnson & Johnson Stock (JNJ) Slips After Record $1.5B Talc Verdict: News, Forecasts, and What to Watch Into 2026

Johnson & Johnson ended Tuesday, December 23, 2025, in the spotlight for reasons that cut both ways for investors: a headline-grabbing talc-related jury verdict that revived long-running legal risk concerns—and a steady drumbeat of regulatory and product updates that reinforce the company’s growth narrative across Innovative Medicine and MedTech.
23 December 2025
··
1 … 4 5 6 7 8 … 42
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY IN STAGES

AerCap

NYSE: AER 95 / 100
#2 BUY ON WEAKNESS

Xylem

NYSE: XYL 93 / 100
#3 ACCUMULATE

General Dynamics

NYSE: GD 91 / 100
#4 BUY WITH LIMITS

Visa

NYSE: V 88 / 100
#5 TACTICAL BUY

IDEX

NYSE: IEX 85 / 100
View full portfolio
Editorial model selection. Not personalised advice.